Journal of the American Society of Nephrology, Vol 3, 1508-1515, Copyright © 1993 by American Society of Nephrology

REGULAR ARTICLES

Peritoneal dialysis fluid inhibition of phagocyte function: effects of osmolality and glucose concentration

T Liberek, N Topley, A Jorres, GA Coles, GM Gahl and JD Williams
Institute of Nephrology, University of Wales College of Medicine, Royal Infirmary, Cardiff, United Kingdom.

Solutions were formulated to examine, independently, the roles of osmolality and glucose in the reduction of viability and inhibition of phagocyte function by dextrose-containing peritoneal dialysis fluids. The exposure of neutrophils (polymorphonuclear leukocytes) to test fluids containing > or = 2.7% (wt/vol) glucose resulted in significant cytotoxicity as assessed by the release of lactate dehydrogenase above control values (7.12 +/- 2.65%). At the highest concentration of glucose (4.5%), lactate dehydrogenase release was 15.83 +/- 0.49% (P < 0.05). These effects were directly related to the presence of D-glucose in the test fluids. In contrast, phagocytosis and the release of leukotriene B4 from PMN stimulated with serum-treated zymosan were significantly inhibited in an osmolality-, but not glucose-, dependent manner. The inhibition of tumor necrosis factor alpha and interleukin-6 release from mononuclear leukocytes was inhibited by a combination of osmolality and monosaccharide concentration. Under the same conditions, PMN respiratory burst activation remained unaffected irrespective of glucose concentration or fluid osmolality. These data indicate that, in addition to the low pH of peritoneal dialysis fluid and its high lactate concentration, its glucose content (either directly or as a consequence of the resulting hyperosmolality of the fluid) inhibits cell functional parameters. These findings suggest clinically significant inhibition of host defense mechanisms because, in high- glucose dialysis fluids, osmolality does not reach physiologic values, even during extended intraperitoneal dwell periods.

This article has been cited by other articles:

				K. Farhat, F. J. van Ittersum, P. M. ter Wee, and C. E. Douma Conventional versus biocompatible peritoneal dialysis fluids: more questions than answers? NDT Plus, October 1, 2008; 1(suppl_4): iv46 - iv50. [Abstract] [Full Text] [PDF]

				Z. E. K. Pogson, T. M. McKeever, and A. Fogarty The association between serum osmolality and lung function among adults Eur. Respir. J., July 1, 2008; 32(1): 98 - 104. [Abstract] [Full Text] [PDF]

				J. Montenegro, R. Saracho, I. Gallardo, I. Martinez, R. Munoz, and N. Quintanilla Use of pure bicarbonate-buffered peritoneal dialysis fluid reduces the incidence of CAPD peritonitis Nephrol. Dial. Transplant., June 1, 2007; 22(6): 1703 - 1708. [Abstract] [Full Text] [PDF]

				S. Mortier, A. S. de Vriese, R. M. McLoughlin, N. Topley, T. P. Schaub, J. Passlick-Deetjen, and N. H. Lameire Effects of Conventional and New Peritoneal Dialysis Fluids on Leukocyte Recruitment in the Rat Peritoneal Membrane J. Am. Soc. Nephrol., May 1, 2003; 14(5): 1296 - 1306. [Abstract] [Full Text] [PDF]

				S. Jones, C. J. Holmes, R. K. Mackenzie, R. Stead, G. A. Coles, J. D. Williams, D. Faict, and N. Topley Continuous Dialysis with Bicarbonate/Lactate-Buffered Peritoneal Dialysis Fluids Results in a Long-Term Improvement in Ex Vivo Peritoneal Macrophage Function J. Am. Soc. Nephrol., January 1, 2002; 13(90001): S97 - 103. [Abstract] [Full Text] [PDF]

				L. M. McManus, R. C. Bloodworth, T. J. Prihoda, J. L. Blodgett, and R. N. Pinckard Agonist-dependent failure of neutrophil function in diabetes correlates with extent of hyperglycemia J. Leukoc. Biol., September 1, 2001; 70(3): 395 - 404. [Abstract] [Full Text] [PDF]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673